Table 4.
Clinimetric Index | Difference from the Original Version | Assessment Time | Final Score | Flare Definition |
---|---|---|---|---|
LAI-P |
|
2 weeks | 0–2.6 | Increase of 0.25 from the last evaluation |
SLEPDAI |
|
10 days | 0–105 | 4–11: moderate activity; > 12: severe activity |
m-SLAM |
|
1 months | 0-81 | ≥7: active disease |
m-ECLAM |
|
1–3 months | 0–17.5 | ≥2: active disease |
BILAG2004-P |
|
4 weeks | A–E | A: severe; B: moderate; C: mild stable disease; D: no disease activity; E: no current or previous disease activity |
Legend: ↑: increase; ↓: reduction; aPL: antiphospholipid antibody; APS: antiphospholipid syndrome; C’: complement; CVA: cardiovascular accident; DD: differential diagnosis; E: eclampsia; ESR: erythrocyte sedimentation rate; FM: fibromyalgia; HELLP: hemolysis, elevated liver enzymes, and low platelets; LN: lupus nephritis; PE: preeclampsia; PGA: physician global assessment; Pt: patient; TP: thrombocytopenia.